Practo has acquired a Bangalore based enterprise healthcare analytics platform called Enlightiks for an undisclosed amount. Enlightiks’ 50 member team will join Practo to form an analytics business unit within Practo to be headed by Enlightiks co-founder and CEO Vamsi Chandra Kasivajjala.
Enlightiks offers Querent, a business analytics platform which provides insights for real time business optimisation. The startup claims that Querent can provide accurate predictions for key business metrics.
Querent uses natural language generation, machine and deep learning to read structured and unstructured data looking at hospital information management systems and other transactional systems. With this, it can provide visuals and insights for multiple departments including operations, finance, quality, pricing and marketing for healthcare enterprises.
Enlightiks claims to have 200 clients including Apollo Sugar Clinics, Kokilaben Dhirubhai Ambani Hospital, Inamdar Multispecialty Hospital, Fernandez Hospitals and Eye-Q Vision. The startup was founded by Shilpa Peri, Venkatesh Pagidimarri, Dr Bas Nair, Vamsi Chandra Kasivajjala, Shaunak Joshi and Sunil Kondala in 2012.
Practo’s previous acquisitions
Practo last acquired Qikwell, a Bangalore based doctor discovery and booking platform, for an undisclosed amount in September last year. Qikwell was Practo’s fourth acquisition in 2015, the others being Insta Health Solutions, an end to end cloud hospital info management solution for $12 million; Genii, a Mumbai based product and development firm for an undisclosed amount and digital fitness solution FitHo for a cash and equity deal.
Practo app users can get both an Ola and Uber within the app. Last year, the company started operations in Malaysia after expanding to Indonesia and Philippines initially. Earlier this year, it appointed Manish Dugar as its global CFO.
Portea’s Health Mantra acquisition
At the start of the year, Practo’s competitor Portea Medical acquired Health Mantra, a company which offered home healthcare equipment and services for sleep apnea and respiratory disorder patients, for an undisclosed cash and stock amount.